Article
Complement-Mediated Events in Alzheimer’s Disease: Mechanisms and Potential Therapeutic Targets
1 Jan 2020
Abstract excerpt
An estimated 5.7 million Americans suffer from Alzheimer's disease in the United States, with no disease-modifying treatments to prevent or treat cognitive deficits associated with the disease. Genome-wide association studies suggest that an enhancement of clearance mechanisms and/or promotion of an anti-inflammatory response may slow or prevent disease progression. Increasing awareness of distinct roles of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
